Search

Your search keyword '"10038 Institute of Clinical Chemistry"' showing total 626 results

Search Constraints

Start Over You searched for: Descriptor "10038 Institute of Clinical Chemistry" Remove constraint Descriptor: "10038 Institute of Clinical Chemistry"
626 results on '"10038 Institute of Clinical Chemistry"'

Search Results

1. Translational opportunities of single-cell biology in atherosclerosis

2. High-density lipoprotein revisited: biological functions and clinical relevance

3. How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology

4. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

5. HDL - Quo vadis

6. Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor-related myocarditis and myositis: rechallenge?

7. Altered Distribution of Unesterified Cholesterol among Lipoprotein Subfractions of Patients with Diabetes Mellitus Type 2

8. Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation

9. Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region

10. Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation

11. Hyperacute T Wave in the Early Diagnosis of Acute Myocardial Infarction

12. The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions

13. Normalization of lipid oxidation defects arising from hypoxia early posthepatectomy prevents liver failure in mouse

14. Long-term effects of l-serine supplementation upon a mouse model of diabetic neuropathy

19. Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis

20. Association of accompanying dyspnea with diagnosis and outcome of patients presenting with acute chest discomfort

22. Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury

23. Performance of the ESC 0/2h-algorithm using high-sensitivity cardiac troponin I in the early diagnosis of myocardial infarction

24. Quantifying inflammation using Interleukin-6 for improved phenotyping and risk stratification in acute heart failure

25. Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction

26. Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1

27. Introducing the new Task Force on Cardiovascular Risk Factors of the European Association of Preventive Cardiology

28. Performance of the American Heart Association/American College of Cardiology/Heart Rhythm Society versus European Society of Cardiology guideline criteria for hospital admission of patients with syncope

29. Deoxy-sphingolipids, oxidative stress, and vitamin C correlate with qualitative and quantitative patterns of small fiber dysfunction and degeneration

30. Brain Endothelial Cells in Contrary to the Aortic Do Not Transport but Degrade Low-Density Lipoproteins via Both LDLR and ALK1

31. Influence of Trimethylamine N-Oxide on Platelet Activation

32. Decoding Functional High-Density Lipoprotein Particle Surfaceome Interactions

33. Diagnostic discrimination of a novel high-sensitivity cardiac troponin I assay and derivation/validation of an assay-specific 0/1h-algorithm

34. Occult hypoperfusion and changes of systemic lipid levels after severe trauma: an analysis in a standardized porcine polytrauma model

35. Adverse effects of polymyxin B administration to healthy horses

36. The spoils of war and the long-term spoiling of health conditions of entire nations

37. Endothelial Barrier Disruption by Lipid Emulsions Containing a High Amount of N3 Fatty Acids (Omegaven) but Not N6 Fatty Acids (Intralipid)

38. A 0/1h-algorithm using cardiac myosin-binding protein C for early diagnosis of myocardial infarction

39. Coronary Flow Evaluation in Heart Transplant Patients Compared to Healthy Controls Documents the Superiority of Coronary Flow Velocity Reserve Companion as Diagnostic and Prognostic Tool

40. International Validation of the Canadian Syncope Risk Score: A Cohort Study

41. Aktueller Stellenwert der HDL-Cholesterin-Bestimmung für die kardiovaskuläre Risikoabschätzung

42. Toward three-dimensional in vitro models to study neurovascular unit functions in health and disease

43. Preliminary Investigation of Side Effects of Polymyxin B Administration in Hospitalized Horses

44. Extracorporeal life support as bridge to recovery in yew poisoning: case reports and literature review

45. Gentamicin plasma concentrations in hospitalized horses and retrospective minimal inhibitory concentrations of gram‐negative equine pathogens

46. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes

47. Genetic pain loss disorders

48. Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial

49. Hybrid nanocomposite as a chest wall graft with improved vascularization by copper oxide nanoparticles

50. Calorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial

Catalog

Books, media, physical & digital resources